Cargando…
Recently Approved and Under Investigation Drugs for Treating Patients with Heart Failure
Heart Failure (HF) represents a leading cause of morbidity and mortality worldwide. Despite the recent advances in the treatment of this condition, patients´ prognosis remains unfavorable in most cases. Sacubitril/valsartan and ivabradine have been recently approved to improve clinical outcomes in p...
Autores principales: | Castro-Torres, Yaniel, Katholi, Richard E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bentham Science Publishers
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7536816/ https://www.ncbi.nlm.nih.gov/pubmed/32351188 http://dx.doi.org/10.2174/1573403X14666180702151626 |
Ejemplares similares
-
Renal Denervation for Treating Resistant Hypertension: Current Evidence and Future Insights from a Global Perspective
por: Castro Torres, Y., et al.
Publicado: (2013) -
Tp-e interval and Tp-e/QTc ratio: new choices for risk stratification of arrhythmic events in patients with hypertrophic cardiomyopathy
por: Castro-Torres, Yaniel
Publicado: (2017) -
Ebanga™: The most recent FDA-approved drug for treating Ebola
por: Taki, Elahe, et al.
Publicado: (2023) -
Recent drug approvals for acute myeloid leukemia
por: Lai, Catherine, et al.
Publicado: (2019) -
CHADS(2) Score: Its Predictive Capacity in Clinical
Practice
por: Torres, Yaniel Castro, et al.
Publicado: (2013)